Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Br J Cancer

Retrieve available abstracts of 25 articles:
HTML format

Single Articles

    May 2024
  1. MEDRANO M, Contreras M, Caballero-Velazquez T, Martinez L, et al
    Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions.
    Br J Cancer. 2024;130:1529-1541.
    PubMed     Abstract available

    March 2024
  2. LITTLE MP, Eidemuller M, Kaiser JC, Apostoaei AI, et al
    Minimum latency effects for cancer associated with exposures to radiation or other carcinogens.
    Br J Cancer. 2024;130:819-829.
    PubMed     Abstract available

    February 2024
  3. LITTLE MP, Mai JZ, Fang M, Chernyavskiy P, et al
    Solar ultraviolet radiation exposure, and incidence of childhood acute lymphocytic leukaemia and non-Hodgkin lymphoma in a US population-based dataset.
    Br J Cancer. 2024 Feb 29. doi: 10.1038/s41416-024-02629.
    PubMed     Abstract available

  4. ZAKKAK N, Barclay ME, Swann R, McPhail S, et al
    The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit.
    Br J Cancer. 2024;130:297-307.
    PubMed     Abstract available

  5. GUTIERREZ-CAMINO A, Richer C, Ouimet M, Fuchs C, et al
    Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia.
    Br J Cancer. 2024;130:317-326.
    PubMed     Abstract available

    January 2024
  6. HEYMER EJ, Hawkins MM, Winter DL, Teepen JC, et al
    Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
    Br J Cancer. 2024 Jan 19. doi: 10.1038/s41416-024-02577.
    PubMed     Abstract available

    October 2023
  7. LITTLE MP, Wakeford R, Zablotska LB, Borrego D, et al
    Radiation exposure and leukaemia risk among cohorts of persons exposed to low and moderate doses of external ionising radiation in childhood.
    Br J Cancer. 2023;129:1152-1165.
    PubMed     Abstract available

    September 2023
  8. LORENZINI T, Cadilha BL, Obeck H, Benmebarek MR, et al
    Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy.
    Br J Cancer. 2023;129:696-705.
    PubMed     Abstract available

    July 2023
  9. GUPTA DG, Varma N, Sreedharanunni S, Abdulkadir SA, et al
    'Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting.
    Br J Cancer. 2023;129:143-152.
    PubMed     Abstract available

    June 2023
  10. BEDICS G, Egyed B, Kotmayer L, Benard-Slagter A, et al
    PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia.
    Br J Cancer. 2023 Jun 21. doi: 10.1038/s41416-023-02309.
    PubMed     Abstract available

    May 2023
  11. CROMIE KJ, Hughes NF, Milner S, Crump P, et al
    Socio-economic and ethnic disparities in childhood cancer survival, Yorkshire, UK.
    Br J Cancer. 2023;128:1710-1722.
    PubMed     Abstract available

    March 2023
  12. LIU HC, Kuo MC, Wu KH, Chen TY, et al
    Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan.
    Br J Cancer. 2023;128:1294-1300.
    PubMed     Abstract available

    February 2023
  13. WANG L, Zhang Q, Ye L, Ye X, et al
    All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARalpha-Nrf2 complex.
    Br J Cancer. 2023;128:691-701.
    PubMed     Abstract available

    November 2022
  14. SUNGUC C, Hawkins MM, Winter DL, Dudley IM, et al
    Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
    Br J Cancer. 2022 Nov 1. pii: 10.1038/s41416-022-02016.
    PubMed     Abstract available

    September 2022
  15. VENN NC, Huang L, Hovorkova L, Muskovic W, et al
    Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.
    Br J Cancer. 2022;127:908-915.
    PubMed     Abstract available

    July 2022
  16. SELLIN M, Mack R, Rhodes MC, Zhang L, et al
    Molecular mechanisms by which splice modulator GEX1A inhibits leukaemia development and progression.
    Br J Cancer. 2022;127:223-236.
    PubMed     Abstract available

    February 2022
  17. JIANG Y, Southam AD, Trova S, Beke F, et al
    Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing.
    Br J Cancer. 2022;126:275-286.
    PubMed     Abstract available

  18. SUBHASH VV, Huang L, Kamili A, Wong M, et al
    Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma.
    Br J Cancer. 2022;126:482-491.
    PubMed     Abstract available

    September 2021
  19. TARIQ MU, Furqan M, Parveen H, Ullah R, et al
    CCT245718, a dual FLT3/Aurora A inhibitor overcomes D835Y-mediated resistance to FLT3 inhibitors in acute myeloid leukaemia cells.
    Br J Cancer. 2021;125:966-974.
    PubMed     Abstract available

    July 2021
  20. MOGENSEN H, Modig K, Talback M, Erdmann F, et al
    Number of siblings and survival from childhood leukaemia: a national register-based cohort study from Sweden.
    Br J Cancer. 2021;125:112-118.
    PubMed     Abstract available

  21. KARSA M, Kosciolek A, Bongers A, Mariana A, et al
    Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin.
    Br J Cancer. 2021;125:55-64.
    PubMed     Abstract available

    May 2021
  22. SONG S, Zhang J, Su Q, Zhang W, et al
    Downregulation of ITGA6 confers to the invasion of multiple myeloma and promotes progression to plasma cell leukaemia.
    Br J Cancer. 2021;124:1843-1853.
    PubMed     Abstract available

    February 2021
  23. PINTO-FERNANDEZ A, Salio M, Partridge T, Chen J, et al
    Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity.
    Br J Cancer. 2021;124:817-830.
    PubMed     Abstract available

    January 2021
  24. BARROW TM, Nakjang S, Lafta F, Bilotkach K, et al
    Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia.
    Br J Cancer. 2021;124:474-483.
    PubMed     Abstract available

    December 2020
  25. PUETT RC, Poulsen AH, Taj T, Ketzel M, et al
    Relationship of leukaemias with long-term ambient air pollution exposures in the adult Danish population.
    Br J Cancer. 2020;123:1818-1824.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.